Literature DB >> 1279436

Control of CFTR chloride conductance by ATP levels through non-hydrolytic binding.

P M Quinton1, M M Reddy.   

Abstract

Site-specific mutation and membrane reconstitution experiments provide compelling evidence that the product of the gene which is at fault in the disease cystic fibrosis, termed the cystic fibrosis transmembrane conductance regulator (CFTR), is a small-conductance chloride channel activated by phosphorylation. As transport of chloride ions is passive, the predicted presence of two nucleotide-binding domains in CFTR seems as puzzling as a report that ATP hydrolysis is essential to activate the channel. We now find that in the sweat duct, which expresses high levels of CFTR and has a very high Cl- conductance, intracellular concentrations of ATP must be about normal (5 mM) for activation of this conductance, apparently by a non-hydrolytic, perhaps allosteric, mechanism. This passive dependence on ATP should mean that even a modest depletion of cell energy levels will significantly lower the energy demands of electrolyte transport by decreasing chloride conductance. We believe this direct coupling between cellular ATP levels and chloride channel activity is an adaptive mechanism to protect the tissue from damage resulting from excessive energy depletion.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1279436     DOI: 10.1038/360079a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  49 in total

1.  Inhibition of ATPase, GTPase and adenylate kinase activities of the second nucleotide-binding fold of the cystic fibrosis transmembrane conductance regulator by genistein.

Authors:  C Randak; E A Auerswald; I Assfalg-Machleidt; W W Reenstra; W Machleidt
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

2.  ACTH induces Cav3.2 current and mRNA by cAMP-dependent and cAMP-independent mechanisms.

Authors:  Haiyan Liu; Judith A Enyeart; John J Enyeart
Journal:  J Biol Chem       Date:  2010-04-27       Impact factor: 5.157

3.  Activation mechanisms for the cystic fibrosis transmembrane conductance regulator protein involve direct binding of cAMP.

Authors:  Malcolm M C Pereira; Jody Parker; Fiona L L Stratford; Margaret McPherson; Robert L Dormer
Journal:  Biochem J       Date:  2007-07-01       Impact factor: 3.857

Review 4.  Frontiers in research on cystic fibrosis: understanding its molecular and chemical basis and relationship to the pathogenesis of the disease.

Authors:  Y H Ko; P L Pedersen
Journal:  J Bioenerg Biomembr       Date:  1997-10       Impact factor: 2.945

5.  CrossTalk proposal: Skeletal muscle oxidative capacity is altered in patients with cystic fibrosis.

Authors:  Paula Rodriguez-Miguelez; Melissa L Erickson; Kevin K McCully; Ryan A Harris
Journal:  J Physiol       Date:  2017-03-01       Impact factor: 5.182

6.  Purinergic control of lysenin's transport and voltage-gating properties.

Authors:  Sheenah Bryant; Nisha Shrestha; Paul Carnig; Samuel Kosydar; Philip Belzeski; Charles Hanna; Daniel Fologea
Journal:  Purinergic Signal       Date:  2016-06-18       Impact factor: 3.765

7.  Dual effects of ADP and adenylylimidodiphosphate on CFTR channel kinetics show binding to two different nucleotide binding sites.

Authors:  F Weinreich; J R Riordan; G Nagel
Journal:  J Gen Physiol       Date:  1999-07       Impact factor: 4.086

8.  Functional expression of mouse mdr1 in Escherichia coli.

Authors:  E Bibi; P Gros; H R Kaback
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

9.  Intracellular ATP and GTP are both required to preserve modulation of N-type calcium channel current by norepinephrine.

Authors:  K S Elmslie; M A Werz; J L Overholt; S W Jones
Journal:  Pflugers Arch       Date:  1993-06       Impact factor: 3.657

10.  PKA mediates constitutive activation of CFTR in human sweat duct.

Authors:  M M Reddy; P M Quinton
Journal:  J Membr Biol       Date:  2009-10-29       Impact factor: 1.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.